✦ LIBER ✦

Interferon alpha-2b as treatment for Philadelphia-negative chronic myeloproliferative disorders with excessive thrombocytosis

✍ Scribed by M. Lazzarino; A. Vitale; E. Morra; A. Gagliardi; P. Bernasconi; C. Torromeo; D. Inverardi; V. Burgio; A. Castello; C. Bernasconi; F. Mandelli

Book ID: 114711871
Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 487 KB
Volume: 72
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1989.tb07679.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of thrombocytosis in chronic m

Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b

✍ Heinz L. Seewann; Ronald Zikulnig; Gertraud Gallhofer; Christine Schmid 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 782 KB

Recombinant interferon-alpha therapy of

Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis

✍ Moshe Talpaz; Razelle Kurzrock; Hagop Kantarjian; Susan O'Brien; Jordan U. Gutte 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 742 KB

Alpha interferon treatment of essential

Alpha interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis

✍ Xenophon Yataganas; John Meletis; Eleni Plata; Nora Viniou; Filippos Deligiannis 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 346 KB

O40 Results of the interferon-alpha 2b t

O40 Results of the interferon-alpha 2b therapy in patients with Ph-negative chronic myeloproliferative disorder

✍ M.A. Sokolova; N.D. Khoroshko; N.V. Tsvetaeva; M.D. Sanatko; A.V. Misurin; V.V. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Cost–utility analysis of different peg-i

Cost–utility analysis of different peg-interferon alpha-2b plus ribavirin treatment strategies as initial therapy for naïve Chinese patients with chronic hepatitis C

✍ W.-A. LIN; Y.-H. TARN; S.-L. TANG 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Rapid clearance of hepatitis C virus RNA

Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatment

✍ K. Peerlinck; M. Willems; L. Sheng; F. Nevens; J. Fevery; S. H. Yap; J. Vermylen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB